Mechanisms of HBV-Induced Innate Immunity
乙型肝炎病毒诱导的先天免疫机制
基本信息
- 批准号:10159072
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-23 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsApoptosisApoptoticApplications GrantsAttenuatedCell DeathCell MaintenanceChronicChronic HepatitisChronic Hepatitis BComplexDataDynaminEventExcisionFibrosisGene ExpressionGenesGoalsHepatitis BHepatitis B VirusHomeostasisHumanImmune signalingInjuryInnate Immune ResponseInterferonsInvestigationLeadLinkLiver MitochondriaLiver diseasesLysineMaintenanceMediatingMediator of activation proteinMetabolicMitochondriaMolecularNatural ImmunityOxidative StressPINK1 geneParkinson DiseasePathogenesisPhosphorylationPhosphotransferasesPhysiologicalPlayPrimary carcinoma of the liver cellsProcessProductionProteinsPublishingReceptor SignalingRisk FactorsRoleSignal TransductionSignaling MoleculeSignaling ProteinTNF receptor-associated factor 3TretinoinUbiquitinationVirus DiseasesWorkchronic infectionchronic liver injurycytochrome cinnate immune pathwaysinsightliver injurymitochondrial autophagynovelparkin gene/proteinprotein functionrecruittherapeutic targetubiquitin-protein ligase
项目摘要
Project Summary/Abstract
Chronic Hepatitis B virus infections affect about 350 million people worldwide and constitute a
significant risk factor for fibrosis and hepatocellular carcinoma (HCC). HBV alters mitochondrial
dynamics. HBV has been shown to induce autophagy of mitochondria (Mitophagy) as evidenced by
Parkin translocation to mitochondria. We propose to investigate a possible link between mitochondrial
dynamics induced by HBV and innate immunity. HBV cripples host innate immunity to maintain
chronic persistent infection. Here, we propose to investigate the molecular mechanisms of HBV-
induced suppression of innate immune signaling from mitochondrial platform. The key player in this
process is a mitochondrial antiviral signaling protein (MAVS). There is sufficient supporting
information, which shows that Parkin, an E3 ubiquitin ligase, interacts with MAVS on the mitochondria
and that Parkin causes the ubiquitination of MAVS. These investigations will elucidate how MAVS is
targeted by Parkin in a supracomplex and affects downstream antiviral signaling of interferon
synthesis. These interactions and ubiquitinations eventually cripple innate immunity. These studies
will provide unique insights into molecular mechanisms of HBV-induced mitochondrial dynamics and
its effects on altering host innate immune response and open new avenues of investigations in the
elucidation of innate immune pathways.
项目概要/摘要
慢性乙型肝炎病毒感染影响全球约 3.5 亿人,并构成
纤维化和肝细胞癌(HCC)的重要危险因素。乙型肝炎病毒改变线粒体
动力学。乙型肝炎病毒已被证明可诱导线粒体自噬(Mitophagy),如下所示:
帕金易位至线粒体。我们建议研究线粒体之间可能的联系
HBV 和先天免疫诱导的动态变化。乙型肝炎病毒会削弱宿主的先天免疫力以维持
慢性持续感染。在这里,我们建议研究 HBV-的分子机制。
诱导抑制线粒体平台的先天免疫信号。这其中的关键人物
过程是线粒体抗病毒信号蛋白(MAVS)。有足够的支撑
信息显示 Parkin(一种 E3 泛素连接酶)与线粒体上的 MAVS 相互作用
Parkin 会导致 MAVS 泛素化。这些调查将阐明 MAVS 是如何
超复合物中的 Parkin 靶向并影响干扰素的下游抗病毒信号传导
合成。这些相互作用和泛素化最终会削弱先天免疫。这些研究
将为 HBV 诱导的线粒体动力学的分子机制提供独特的见解,
它对改变宿主先天免疫反应的影响并开辟了新的研究途径
阐明先天免疫途径。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Monitoring Mitochondrial Function in Aedes albopictus C6/36 Cell Line during Dengue Virus Infection.
- DOI:10.3390/insects12100934
- 发表时间:2021-10-14
- 期刊:
- 影响因子:3
- 作者:Santana-Román ME;Maycotte P;Uribe-Carvajal S;Uribe-Alvarez C;Alvarado-Medina N;Khan M;Siddiqui A;Pando-Robles V
- 通讯作者:Pando-Robles V
The role of N6-methyladenosine modification in the life cycle and disease pathogenesis of hepatitis B and C viruses.
- DOI:10.1038/s12276-021-00581-3
- 发表时间:2021-03
- 期刊:
- 影响因子:12.8
- 作者:Kim GW;Siddiqui A
- 通讯作者:Siddiqui A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEEM SIDDIQUI其他文献
ALEEM SIDDIQUI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEEM SIDDIQUI', 18)}}的其他基金
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10092086 - 财政年份:2019
- 资助金额:
$ 38.75万 - 项目类别:
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10361391 - 财政年份:2019
- 资助金额:
$ 38.75万 - 项目类别:
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10569036 - 财政年份:2019
- 资助金额:
$ 38.75万 - 项目类别:
2016 Internatinal Meeting o the Molecular Biology of Hepatitis B Viruses
2016乙型肝炎病毒分子生物学国际会议
- 批准号:
9124150 - 财政年份:2016
- 资助金额:
$ 38.75万 - 项目类别:
Intervention of HBV DNA synthesis and transcription
干预 HBV DNA 合成和转录
- 批准号:
8511268 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
Intervention of HBV DNA synthesis and transcription
干预 HBV DNA 合成和转录
- 批准号:
8731176 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
Role of Lipids in Hepatitis C Virus Maturation
脂质在丙型肝炎病毒成熟中的作用
- 批准号:
8484783 - 财政年份:2010
- 资助金额:
$ 38.75万 - 项目类别:
Role of Lipids in Hepatitis C Virus Maturation
脂质在丙型肝炎病毒成熟中的作用
- 批准号:
8286215 - 财政年份:2010
- 资助金额:
$ 38.75万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:














{{item.name}}会员




